CVS Health shares are trading higher after TD Cowen upgraded the stock from Hold to Buy and raised its price target from $59 to $85.
Portfolio Pulse from Benzinga Newsdesk
CVS Health shares rose following an upgrade by TD Cowen from Hold to Buy, with a price target increase from $59 to $85.
October 04, 2024 | 2:10 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
CVS Health's stock received a boost after TD Cowen upgraded it from Hold to Buy and increased the price target from $59 to $85, indicating positive sentiment and potential for price appreciation.
The upgrade from Hold to Buy by TD Cowen suggests increased confidence in CVS Health's future performance. The raised price target from $59 to $85 indicates expectations of significant price appreciation, likely leading to increased investor interest and a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100